JEF - Jefferies Financial Group Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
17.17
+0.68 (+4.09%)
As of 3:17PM EDT. Market open.
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close16.49
Open16.94
Bid17.16 x 1200
Ask17.17 x 1000
Day's Range16.73 - 17.22
52 Week Range11.20 - 24.03
Volume1,808,422
Avg. Volume2,836,920
Market Cap4.577B
Beta (5Y Monthly)1.44
PE Ratio (TTM)13.05
EPS (TTM)1.32
Earnings DateSep 24, 2020 - Sep 28, 2020
Forward Dividend & Yield0.60 (3.69%)
Ex-Dividend DateAug 14, 2020
1y Target Est21.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-12% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Will Jefferies (JEF) Gain on Rising Earnings Estimates?
    Zacks

    Will Jefferies (JEF) Gain on Rising Earnings Estimates?

    Jefferies (JEF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

  • Bloomberg

    Assassin's Creed Maker Finally Confronts Its Toxic Culture

    (Bloomberg Opinion) -- All the warning signs were there: An industry that’s long struggled with sexism; an overwhelmingly male workforce; an emphasis on the privileged role of the creative mind.Yet it still took three years for the MeToo reckoning to catch up with Ubisoft SA. The maker of the video games Assassin’s Creed and Far Cry said on Sunday that three of its top executives would depart amid an internal review into a slew of sexual harassment allegations made over the past month.The departures came after the French newspaper Liberation published a second installment of insider accounts on Friday of a “boys’ club” culture at the company, which it said was fostered by Chief Creative Officer Serge Hascoet. He resigned alongside human resources chief Cecile Cornet and Yannis Mallat, the head of Ubisoft’s studios in Canada, where much of the alleged behavior took place. The scandal should refocus boardroom attention on fixing corporate cultures that promote toxicity. The first step has to be ensuring there are processes are in place to detect and identify such environments, that there are reporting channels and that complaints of misconduct are taken seriously.The Liberation report said that Hascoet, who it described as Ubisoft Chief Executive Officer Yves Guillemot’s second-in-command, had witnessed sexual harassment first-hand, turned a blind eye to accusations and enabled a toxic culture — though it said he wasn’t personally guilty of harassment. Those who complained were told that was simply how creatives behaved, and that they should leave if they couldn’t handle it, the newspaper reported.Cornet meanwhile built a human resources function that did little to protect female workers, according to the newspaper. Citing unidentified Ubisoft employees, Liberation reported that when the company introduced a tool to allow employees to report potential corruption, Cornet explicitly rejected a push to open it up for claims of harassment as well, a move that was reversed last week.The company didn't directly address any of the specific accusations in a statement released later on Sunday. But it did commit to implementing significant changes in its workplace culture. It said Guillemot will personally oversee an overhaul of the way in which Ubisoft’s creative teams collaborate. The company will audit and reshape its human resources procedures to handle “new challenges” in the industry.Sexism has long been a problem in the video game industry. Not only are female gamers three times as likely to receive online abuse as men, according to a 2015 study, there have also been problems with how women are portrayed in games (often either scantily clad or as damsels in distress) and with discrimination besetting the proportionately few women who work behind the scenes. Earlier efforts to fix these problems seem to have made little headway: In 2012 women in the gaming industry took to social media using the hashtag 1reasonwhy with anecdotes about the obstacles (and worse) they’d encountered. In 2014 the Gamergate affair revealed widespread harassment. Tencent Ltd.-owned Riot Games last year offered to pay at least $10 million in order to settle a class action lawsuit over alleged gender discrimination.Those that don’t take harassment seriously face repercussions, not least by making it hard to hire top female talent. In its most recent annual report, Ubisoft reported a 78% male workforce, noting this was similar to the rest of the industry.Because many of the Ubisoft allegations focus on Canada, it may leave the French company more financially exposed too. It currently receives more than 100 million euros ($113 million) in subsidies and tax breaks there, thanks in part to a Quebecois tax credit that can top 37% of labor expenses. It’s a measure that has been the subject of vociferous criticism, not least from other tech executives, for benefiting foreign companies at the expense of the region’s homegrown firms. The harassment allegations might prompt politicians to think again. Ending the Canadian subsidies would have severe financial implications for Ubisoft, since they alone reduce global payroll costs by 11%.The company has been rattled by its early mismanagement of employees’ well-being, and is now trying to act fast to handle the fallout with the departure of three top execs. The upheaval could disrupt the release schedule for its upcoming games, analysts at Jefferies Financial Group Inc. wrote on Monday.  That would cause an even bigger headache for a company that already delayed the launch of three games last year, after two of its tentpole releases — Ghost Recon Breakpoint and Tom Clancy’s The Division 2 — missed expectations. The shakeup at Ubisoft is a timely reminder that failing to fix a rotting company culture has deep ramifications.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Alex Webb is a Bloomberg Opinion columnist covering Europe's technology, media and communications industries. He previously covered Apple and other technology companies for Bloomberg News in San Francisco.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Jefferies Group LLC Appoints Matthew Larson as Its Chief Financial Officer
    Business Wire

    Jefferies Group LLC Appoints Matthew Larson as Its Chief Financial Officer

    Jefferies Group LLC ("Jefferies Group") announced today that, effective August 24, 2020, Matthew Larson will become Jefferies Group’s Chief Financial Officer, succeeding Teresa Gendron, who has been Jefferies Group’s Interim Financial Officer since the untimely illness and death of its former CFO, Peg Broadbent.

  • Did Hedge Funds Make The Right Call On Jefferies Financial Group Inc. (JEF) ?
    Insider Monkey

    Did Hedge Funds Make The Right Call On Jefferies Financial Group Inc. (JEF) ?

    How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

  • Reuters

    Apax mulls sale of Neuraxpharm to lock in pharma sector premium -sources

    Buyout group Apax is preparing the sale of German pharma group Neuraxpharm to try to lock in high valuations in the healthcare sector, fuelled by the coronavirus pandemic, sources familiar with the matter said. Apax has already held talks with several private equity firms to gauge their interest in the maker of antidepressants, painkillers and other products for the central nervous system and which could be valued at 1.2-1.4 billion euros, they said. An auction of the generics maker, which also sells medical cannabis, could launch in the European autumn, some of the people said, while other sources said Apax might opt to allow for more time before kicking off a sales process.

  • Reuters

    Jefferies sees jump in mergers of equals as coronavirus hammers economy

    Jefferies Financial Group said it expects a jump in mergers of equals in the current coronavirus-stricken economic environment as companies look at cost-effective ways of increasing their scale to survive the crisis. The mergers-of-equals transactions can help companies cut expenses and boost earnings without the "stigma of transacting at lower values, premiums or multiples," Jefferies said in its July newsletter. "In the current economic environment, scale has become only more critical, as the impact of the COVID-19 pandemic has cast a harsh spotlight on sub-scale enterprises," Jefferies said.

  • Investing.com

    Jefferies Financial Earnings, Revenue Beat in Q2

    Investing.com - Jefferies (NYSE:JEF) Financial reported on Monday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

  • Jefferies (JEF) Q2 Earnings and Revenues Beat Estimates
    Zacks

    Jefferies (JEF) Q2 Earnings and Revenues Beat Estimates

    Jefferies (JEF) delivered earnings and revenue surprises of 277.78% and 55.12%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Jefferies sees earnings boost from bond trading despite coronavirus-hit economy
    Yahoo Finance

    Jefferies sees earnings boost from bond trading despite coronavirus-hit economy

    Jefferies is considered a bellwether for the banking sector.

  • Business Wire

    Jefferies Financial Group Announces Second Quarter 2020 Financial Results -- Jefferies Group LLC Records Record Six Months Revenues and Net Income for First Half 2020

    Jefferies Financial Group Inc. (NYSE: JEF) today announced its financial results for the three and six month periods ended May 31, 2020. In addition, the Jefferies Board of Directors declared a quarterly cash dividend equal to $0.15 per Jefferies common share payable on August 28, 2020 to record holders of Jefferies common shares on August 17, 2020. The Jefferies Board of Directors also increased the Company's stock buyback authorization by $177 million to a total of $250 million. We expect to file our Form 10-Q on or about July 9, 2020.

  • Earnings Preview: Jefferies (JEF) Q2 Earnings Expected to Decline
    Zacks

    Earnings Preview: Jefferies (JEF) Q2 Earnings Expected to Decline

    Jefferies (JEF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • CureVac to Work With Bank of America, Jefferies on IPO
    Bloomberg

    CureVac to Work With Bank of America, Jefferies on IPO

    (Bloomberg) -- CureVac AG, a player in the hotly contested race for a coronavirus vaccine and soon to be partly owned by the German government, is working with Bank of America Corp. and Jefferies Financial Group Inc. on a U.S. initial public offering, according to people familiar with the matter.The vaccine maker, based in Tuebingen, Germany, could raise $150 million to $200 million, valuing the company at $1 billion, said the people, who asked not to be identified because the information wasn’t public. That valuation could change depending on whether regulators approve a vaccine.CureVac Chief Financial Officer Pierre Kemula said in an interview Monday that the company was considering an IPO. Other companies trying to develop coronavirus vaccines, including Moderna Inc. and BioNTech SE, are already public.“At this stage we have sufficient amount of capital coming in to decide either way,” Kemula said at the time.According to a German government document, the company is planning to list its shares on the Nasdaq stock market in mid July.A spokesperson for CureVac didn’t immediately respond to a request for comment after regular business hours. Representatives for Bank of America and Jefferies declined to comment.Transatlantic WrangleAs the coronavirus pandemic took hold, CureVac became the prize in a transatlantic competition to secure access to a potential vaccine after reports that the U.S. was angling to buy the company or its technology. Chancellor Angela Merkel’s government responded in June with an agreement to acquire 23% of CureVac for 300 million euros ($336 million) via development bank Kreditanstalt fuer Wiederaufbau, known as KfW.“Germany is not for sale,” Economy Minister Peter Altmaier said at a press conference at the time. “We aren’t selling off the family silver. I am a great supporter of a global free-market economy, but there are certain areas where our position must be very clear.”The investment gives the German state a foothold in an unproven but promising area of pharmaceutical development known as messenger RNA, in which the vaccine teaches the body’s cells to identify and attack the virus. In terms of potential speed to market, CureVac’s experimental product is slightly behind that of frontrunners Moderna, based in Cambridge, Massachusetts, and German rival BioNTech.CureVac, founded in 2000, said in a statement Wednesday that it had received regulatory approval to begin Phase 1 clinical trials of its Covid-19 vaccine candidate.Trump MeetingIn March, CureVac denied speculation that the U.S. government tried to buy the business or its technology.Former CureVac Chief Executive Officer Dan Menichella attended a White House meeting on March 2 with President Donald Trump, along with other developers of potential Covid-19 vaccines. A week later, CureVac’s board replaced Menichella with founder Ingmar Hoerr, saying he was a better choice to lead the company while it’s trying to prove it can produce a vaccine at scale with messenger-RNA technology. Hoerr then stepped down because of a health issue unrelated to the coronavirus.(Updates with Jefferies response in sixth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Hedge Funds Never Been Less Bullish On Jefferies Financial Group Inc. (JEF)
    Insider Monkey

    Hedge Funds Never Been Less Bullish On Jefferies Financial Group Inc. (JEF)

    Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

  • Jefferies' Clients, Employees and Shareholders Contribute $9,250,000 to Over 85 Charities for Coronavirus Relief in Memory of Peg Broadbent
    Business Wire

    Jefferies' Clients, Employees and Shareholders Contribute $9,250,000 to Over 85 Charities for Coronavirus Relief in Memory of Peg Broadbent

    Jefferies announced today a total donation to over 85 different charities of $9.25 million as a result of a firmwide global effort to raise money to honor the memory of their late CFO Peg Broadbent, who was a victim of this terrible disease.

  • Jefferies to Hold Global Coronavirus Relief Charity Day Today Dedicated to the Memory of Peg Broadbent
    Business Wire

    Jefferies to Hold Global Coronavirus Relief Charity Day Today Dedicated to the Memory of Peg Broadbent

    Jefferies announced that it is holding its Global Coronavirus Relief Charity Day today. The firm and its staff will contribute to global charities and relief efforts to assist those suffering from the devastation caused by the Coronavirus global pandemic and will offer investors around the world the opportunity to join these efforts by trading with Jefferies. Jefferies will dedicate this entire effort to their late CFO Peg Broadbent, who was a victim of this terrible disease.

  • Jefferies to Hold Global Coronavirus Relief Charity Day Dedicated to the Memory of Peg Broadbent on May 27th
    Business Wire

    Jefferies to Hold Global Coronavirus Relief Charity Day Dedicated to the Memory of Peg Broadbent on May 27th

    Jefferies confirmed today that it will hold a Global Coronavirus Relief Charity Day tomorrow, Wednesday, May 27, 2020. The firm and its staff will contribute to global charities and relief efforts to assist those suffering from the devastation caused by the Coronavirus global pandemic and will offer investors around the world the opportunity to join these efforts by trading with Jefferies. Jefferies will dedicate this entire effort to their late CFO Peg Broadbent, who was a victim of this terrible disease.

  • How Jefferies Financial Group Inc. (NYSE:JEF) Can Impact Your Portfolio Volatility
    Simply Wall St.

    How Jefferies Financial Group Inc. (NYSE:JEF) Can Impact Your Portfolio Volatility

    Anyone researching Jefferies Financial Group Inc. (NYSE:JEF) might want to consider the historical volatility of the...